Related references
Note: Only part of the references are listed.Lowering blood cholesterol does not affect neuroinflammation in experimental autoimmune encephalomyelitis
Solenne Vigne et al.
JOURNAL OF NEUROINFLAMMATION (2022)
Body mass index as a predictor of MS activity and progression among participants in BENEFIT
Juan Manuel Escobar et al.
MULTIPLE SCLEROSIS JOURNAL (2022)
Childhood Maltreatment and Psychiatric Comorbidity in Immune-Mediated Inflammatory Disorders
Anthony Wan et al.
PSYCHOSOMATIC MEDICINE (2022)
Myocardial infarction and stroke risks in multiple sclerosis patients: A two-sample Mendelian randomization study
Haoxin Peng et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)
Measuring productivity loss in early relapsing-remitting multiple sclerosis
Susana Sainz de la Maza et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2022)
Impact of comorbidities on the disability progression in multiple sclerosis
Gorica Maric et al.
ACTA NEUROLOGICA SCANDINAVICA (2022)
Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patients
Ilkka Rauma et al.
JOURNAL OF NEUROLOGY (2022)
Risk of depression in multiple sclerosis across disease-modifying therapies
Elisa Longinetti et al.
MULTIPLE SCLEROSIS JOURNAL (2022)
Emergency medical care for multiple sclerosis: A five-year population study in the Campania Region (South Italy)
Marcello Moccia et al.
MULTIPLE SCLEROSIS JOURNAL (2022)
Effect of Vascular Comorbidity on Visual and Disability Outcomes in a Secondary Progressive Multiple Sclerosis Clinical Trial Cohort
Kathleen Shangraw et al.
International Journal of MS Care (2022)
Multimorbidity
Soren T. Skou et al.
NATURE REVIEWS DISEASE PRIMERS (2022)
Multiple Sclerosis and the Risk of Cardiovascular Diseases: A Mendelian Randomization Study
Fangkun Yang et al.
FRONTIERS IN IMMUNOLOGY (2022)
The Framingham cardiovascular risk score and 5-year progression of multiple sclerosis
Martina Petruzzo et al.
EUROPEAN JOURNAL OF NEUROLOGY (2021)
Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis
Lara Marie Pangan Lo et al.
JOURNAL OF NEUROLOGY (2021)
Effect of mood and anxiety disorders on health care utilization in multiple sclerosis
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Anxiety and depression affect performance on the symbol digit modalities test over time in MS and other immune disorders
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
School performance, psychiatric comorbidity, and healthcare utilization in pediatric multiple sclerosis: A nationwide population-based observational study
Magnus Spangsberg Boesen et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Vascular comorbidity is associated with lower brain volumes and lower neuroperformance in a large multiple sclerosis cohort
Kathryn C. Fitzgerald et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Depression in multiple sclerosis across the adult lifespan
Carol K. Chan et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Safety of Newer Disease Modifying Therapies in Multiple Sclerosis
Georges Jalkh et al.
VACCINES (2021)
Genome-wide genetic links between amyotrophic lateral sclerosis and autoimmune diseases
Chun Yu Li et al.
BMC MEDICINE (2021)
Depression and multiple sclerosis: A bidirectional Mendelian randomisation study
Stefanie Binzer et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Mendelian randomization provides no evidence for a causal role in the bidirectional relationship between depression and multiple sclerosis
Adil Harroud et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Investigating the shared genetic architecture between multiple sclerosis and inflammatory bowel diseases
Yuanhao Yang et al.
NATURE COMMUNICATIONS (2021)
Health Disparities, Inequities, and Social Determinants of Health in Multiple Sclerosis and Related Disorders in the US A Review
Lilyana Amezcua et al.
JAMA NEUROLOGY (2021)
Comorbidity and persistence of disease-modifying therapy use in relapsing remitting multiple sclerosis
Natalie E. Parks et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Breast Cancer Survival in Multiple Sclerosis A Matched Cohort Study
Ruth Ann Marrie et al.
NEUROLOGY (2021)
High prevalence of comorbidities at diagnosis in immigrants with multiple sclerosis
Dalia Rotstein et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Hypertension and hypertension severity in Hispanics/Latinx with MS
Michael Robers et al.
MULTIPLE SCLEROSIS JOURNAL (2021)
Interface of Multiple Sclerosis, Depression, Vascular Disease, and Mortality A Population-Based Matched Cohort Study
Raffaele Palladino et al.
NEUROLOGY (2021)
Colorectal Cancer Survival in Multiple Sclerosis A Matched Cohort Study
Ruth Ann Marrie et al.
NEUROLOGY (2021)
Higher Framingham Risk Scores are associated with greater loss of brain volume over time in multiple sclerosis
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
Lung cancer risk in patients with multiple sclerosis: a Mendelian randomization analysis
Fan Ge et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)
The Effect of Body Mass Index on Brain Volume and Cognitive Function in Relapsing-Remitting Multiple sclerosis: A CombiRx Secondary Analysis
Aliza Bitton Ben-Zacharia et al.
JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE (2021)
Dissociable cognitive patterns related to depression and anxiety in multiple sclerosis
Victoria M. Leavitt et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Disparities in management and outcomes of myocardial infarction in multiple sclerosis: A matched cohort study
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study
Nina Grytten et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Incident cardiovascular disease in patients diagnosed with multiple sclerosis: A multi-database study
Rebecca Persson et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Risk of Mortality in Immigrants with Multiple Sclerosis in Ontario, Canada
Dalia Rotstein et al.
NEUROEPIDEMIOLOGY (2020)
Prognostic impact of epilepsy in multiple sclerosis
Zamzam Mahamud et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Evaluating the Risk of Macrovascular Events and Mortality Among People With Multiple Sclerosis in England
Raffaele Palladino et al.
JAMA NEUROLOGY (2020)
Impact of comorbidity on hospitalizations in individuals newly diagnosed with multiple sclerosis: A longitudinal population-based study
Lina Al-Sakran et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Management of diabetes and hypertension in people with multiple sclerosis
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Association of body mass index with longitudinal rates of retinal atrophy in multiple sclerosis
Angeliki G. Filippatou et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis
Yujie Wang et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Machine-learning models for depression and anxiety in individuals with immune-mediated inflammatory disease
Lana G. Tennenhouse et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2020)
Comorbidity is associated with disease activity in MS Findings from the CombiRx trial
Amber Salter et al.
NEUROLOGY (2020)
Does obesity exacerbate brain lesion volume and atrophy in patients with multiple sclerosis?
Rachel Galioto et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Bipolar disorders and deep grey matter in multiple sclerosis: A preliminary quantitative MRI study
L. Lorefice et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Comorbidity effect on processing speed test and MRI measures in multiple sclerosis patients
Justin R. Abbatemarco et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Prevalence of comorbidities in Multiple Sclerosis and impact on physical disability according to disease phenotypes
Ethel Ciampi et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
Employment status of people with multiple sclerosis in relation to 10-year changes in functioning and perceived impact of the disease
David Moulaee Conradsson et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2020)
The impact of vascular risk factors on brain volume and lesion load in patients with early multiple sclerosis
Alexander Pichler et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
The impact of vascular risk factors on brain volume and lesion load in patients with early multiple sclerosis
Alexander Pichler et al.
MULTIPLE SCLEROSIS JOURNAL (2019)
Lifestyle and Environmental Factors in Multiple Sclerosis
Lars Alfredsson et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2019)
Hypertension and heart disease are associated with development of brain atrophy in multiple sclerosis: a 5-year longitudinal study
D. Jakimovski et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Lipid-related genetic polymorphisms significantly modulate the association between lipids and disability progression in multiple sclerosis
Yan Zhang et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)
Multiple sclerosis and cancer incidence: A Danish nationwide cohort study
M. Norgaard et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Environmental and genetic risk factors for MS: an integrated review
Emmanuelle Waubant et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)
Epilepsy and associated mortality in patients with multiple sclerosis
I. J. Chou et al.
EUROPEAN JOURNAL OF NEUROLOGY (2019)
Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders
Christiane E. Whitehouse et al.
NEUROLOGY (2019)
Assessing the burden of vascular risk factors on brain atrophy in multiple sclerosis: A case- control MRI study
L. Lorefice et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Diabetes and anxiety adversely affect cognition in multiple sclerosis
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2019)
Psychiatric comorbidity increases mortality in immune-mediated inflammatory diseases
Ruth Ann Marrie et al.
GENERAL HOSPITAL PSYCHIATRY (2018)
Autoimmune comorbidities in multiple sclerosis: what is the influence on brain volumes? A case-control MRI study
Lorena Lorefice et al.
JOURNAL OF NEUROLOGY (2018)
Effects of physical comorbidities on disability progression in multiple sclerosis
Tingting Zhang et al.
NEUROLOGY (2018)
Cognition in multiple sclerosis: State of the field and priorities for the future
James F. Sumowski et al.
NEUROLOGY (2018)
The multiple sclerosis risk allele within the AHI1 gene is associated with relapses in children and adults
Jennifer S. Graves et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
The validity and reliability of screening measures for depression and anxiety disorders in multiple sclerosis
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Exploring the role of physical activity and exercise for managing vascular comorbidities in people with multiple sclerosis: A scoping review
Benjamin W. Ewanchuk et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Adverse psychiatric effects of disease-modifying therapies in multiple Sclerosis: A systematic review
Majid Gasim et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2018)
Body mass index, but not vitamin D status, is associated with brain volume change in MS
Ellen M. Mowry et al.
NEUROLOGY (2018)
Treatment and comorbidities of multiple sclerosis in an employed population in Japan: analysis of health claims data
Mieko Ogino et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2018)
Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study
Kyla A. McKay et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Determinants of non-adherence to disease-modifying therapies in multiple sclerosis: A cross-Canada prospective study
Kyla A. McKay et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Increased incidence of psychiatric disorders in immune-mediated inflammatory disease
Ruth Ann Marrie et al.
JOURNAL OF PSYCHOSOMATIC RESEARCH (2017)
Evaluating the safety of β-interferons in MS A series of nested case-control studies
Hilda J. I. de Jong et al.
NEUROLOGY (2017)
Assessing association of comorbidities with treatment choice and persistence in MS A real-life multicenter study
Alice Laroni et al.
NEUROLOGY (2017)
Comorbidity increases the risk of relapse in multiple sclerosis A prospective study
Kaarina Kowalec et al.
NEUROLOGY (2017)
Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios
Ali Manouchehrinia et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis
Natalie Kappus et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2016)
Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis
R. Zivadinov et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research?
Guowei Li et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2016)
Anxiety and Depressive Symptoms Are Associated With Worse Performance on Objective Cognitive Tests in MS
Sarah A. Morrow et al.
JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES (2016)
Health-related quality of life in multiple sclerosis Direct and indirect effects of comorbidity
Lindsay I. Berrigan et al.
NEUROLOGY (2016)
Recommendations for observational studies of comorbidity in multiple sclerosis
Ruth Ann Marrie et al.
NEUROLOGY (2016)
Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis
Tingting Zhang et al.
NEUROLOGY (2016)
Immunologic Effects of Metformin and Pioglitazone Treatment on Metabolic Syndrome and Multiple Sclerosis
Laura Negrotto et al.
JAMA NEUROLOGY (2016)
Systematic review and meta-analysis of interventions for depression and anxiety in persons with multiple sclerosis
K. M. Fiest et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Prevalence of Comorbidities, Overweight and Obesity in an International Sample of People with Multiple Sclerosis and Associations with Modifiable Lifestyle Factors
Claudia Helena Marck et al.
PLOS ONE (2016)
Examining the joint effect of disability, health behaviors, and comorbidity on mortality in MS
Amber Salter et al.
NEUROLOGY-CLINICAL PRACTICE (2016)
Epidemiology of multiple sclerosis: results from a large observational study in the UK
Susan S. Jick et al.
JOURNAL OF NEUROLOGY (2015)
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Effect of comorbidity on mortality in multiple sclerosis
Ruth Ann Marrie et al.
NEUROLOGY (2015)
The PRECIS-2 tool: designing trials that are fit for purpose
Kirsty Loudon et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
The PRECIS-2 tool: designing trials that are fit for purpose
Kirsty Loudon et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview
Ruth Ann Marrie et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Comorbidity is associated with pain-related activity limitations in multiple sclerosis
K. M. Fiest et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2015)
Increased contrast enhancing lesion activity in relapsing-remitting multiple sclerosis migraine patients
Elliot Graziano et al.
NEUROIMAGE-CLINICAL (2015)
Quality of Care for Patients with Multiple Chronic Conditions: The Role of Comorbidity Interrelatedness
Donna M. Zulman et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2014)
Adaptive enrichment designs for clinical trials
Noah Simon et al.
BIOSTATISTICS (2013)
Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course
Ilya Kister et al.
JOURNAL OF HEADACHE AND PAIN (2010)
Cognitive impairment in multiple sclerosis
Nancy D. Chiaravalloti et al.
LANCET NEUROLOGY (2008)
Causes and consequences of comorbidity: A review
R Gijsen et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)